MeiraGTx Announces Exclusive Licensing Agreement with National Institutes of Health for Gene Therapy Treatment for Sjögren's Syndrome and Associated Xerostomia or Xerophthalmia
Stock Information for MeiraGTx Holdings plc
Loading
Please wait while we load your information from QuoteMedia.